Related Experiment Video
Updated: Dec 24, 2025

06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.7K
Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b
Carlos Rocha-de-Lossada1, Carmen Alba-Linero1, Davide Borroni2
1Hospital Regional Universitario de Málaga, Servicio de Oftalmología, Spain.
Romanian Journal of Ophthalmology
|April 16, 2020
Summary
Topical interferon alfa-2b (IFN-α-2β) effectively treated conjunctival intraepithelial neoplasia (CIN), leading to complete lesion regression. Conjunctival impression cytology proved a valuable, non-invasive tool for diagnosing and monitoring CIN.
Area of Science:
- Ophthalmology
- Oncology
- Cytopathology
Background:
- Conjunctival intraepithelial neoplasia (CIN) is a pre-malignant ocular surface lesion.
- Recurrence after surgical excision necessitates effective adjuvant therapies.
- Accurate diagnosis and monitoring are crucial for managing CIN.
Observation:
- A patient with recurrent CIN presented with a large conjunctival lesion.
- Conjunctival impression cytology confirmed the diagnosis of CIN.
- The lesion was treated with topical interferon alfa-2b (IFN-α-2β) as adjuvant therapy post-surgery.
Findings:
- Topical IFN-α-2β treatment resulted in significant lesion involution within one month.
- Complete regression of the CIN lesion was achieved after six months of treatment.
- Conjunctival impression cytology was utilized for ongoing follow-up.
Implications:
- Topical IFN-α-2β demonstrates potential as a chemoreductive and curative agent for CIN.
- Conjunctival impression cytology is a useful, non-invasive method for CIN diagnosis and follow-up.
- This approach may offer an alternative or adjunct to traditional surgical management of CIN.
Related Concept Videos
Open Angle Glaucoma: Treatment
887
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
887
Angle Closure Glaucoma: Treatment
1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K

